National Drug Abuse Treatment 

 FLORIDA NODE


FLORIDA NODE

José Szapocznik, Ph.D. [email]
Principal Investigator

Director
Center for Family Studies
Miller School of Medicine
University of Miami
1425 NW 10th Ave, Room 309
Miami, FL 33136
http://www.nida.nih.gov/CTN/centers/florida.html (NIDA)

The Florida Node joined the Clinical Trials Network in September 2000. This Node includes the Center for Family Studies in the Miller School of Medicine at the University of Miami (the Regional Research and Training Center (RRTC)) and community treatment programs in Florida and Puerto Rico. These CTPs serve urban and semi-rural areas, and treat an ethnically and racially diverse population. The five founding CTPs are leaders in innovative service programs and the development of drug abuse treatment in the State of Florida. The node has considerable expertise in: 1) adolescent family treatment, 2) treatment for HIV/AIDS populations, 3) aggressive engagement of drug abusers into treatment, and 4) microanalysis of family therapy clinical process. The node has a special interest and expertise with Spanish speaking populations both in the US and abroad.


  Find publications in the Library with Florida involvement

  FLORIDA NODE PROTOCOL INVOLVEMENT

CTN-0001 Buprenorphine/Naloxone versus Clonidine for Inpatient Opiate Detoxification

CTN-0008 Assessment of the National Drug Abuse Clinical Trials Network: A Baseline for Investigating Diffusion of Innovation

CTN-0012 Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections in Substance Abuse Treatment Programs

CTN-0014 Brief Strategic Family Therapy for Adolescent Drug Abusers

CTN-0014-A-1 Mediators and Moderators of Brief Strategic Family Therapy (BSFT) for Adolescent Drug Use

CTN-0015 Women's Treatment for Trauma and Substance Use Disorders

CTN-0021 Motivational Enhancement Treatment to Improve Treatment Engagement and Outcome for Spanish-Speaking Individuals Seeking Treatment for Substance Abuse

CTN-0028 Attention Deficit Hyperactivity Disorder (ADHD) in Adolescents (with Substance Use Disorder)

CTN-0031 Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement

CTN-0032 HIV Rapid Testing and Counseling

CTN-0032-A-1 Economic Analysis of HIV Rapid Testing in Drug Abuse Treatment Programs

CTN-0037 Exercise as a Treatment for Substance Use Disorders

CTN-0044 Web-Delivery of Evidence-Based, Psychosocial Treatment for Substance Use Disorders

CTN-0045-Ot Rates of HIV Testing and Barriers to Testing in African Americans Receiving Substance Abuse Treatment

CTN-0046 Smoking Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking Cessation and Stimulant Treatment on Stimulant Dependence

 


 

 

 

 

 


Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 7/2010 -- http://ctndisseminationlibrary.org/nodes/flnode.htm
info@ctndisseminationlibrary.org